Table 5.
Clinical outcomes.
| ALL n = 74 |
EP n = 43 |
PD n = 31 |
p-value | |
|---|---|---|---|---|
| Complete resection, n (%) | 55 (74.3) | 21 (48.8) | 31 (100) | < 0.001 |
| Recurrence, n (%) | 8 (10.8) | 7 (16.3) | 1 (3.2) | 0.128 |
| Median duration of recurrence, month (range) | 6.2 (1.0–26.1) | 6.1 (1.0–26.1) | 15.9 (15.9) | – |
| Additional treatment for recurrence, n (%) | ||||
| APC | 6 (8.1) | 6 (13.9) | – | |
| EP | 1 (1.4) | 1 (2.3) | – | |
| Chemotherapy | 1 (1.4) | – | 1 (3.2) | |
| Median length of hospital stay, day (range) | 17 (7–68) | 11 (7–57) | 42 (14–68) | < 0.001 |
| Readmission, n (%) | 19 (25.7) | 12 (27.9) | 7 (22.6) | 0.788 |
| Death, n (%) | 4 (5.4) | 1 (2.3) | 3 (9.7) | 0.302 |
| Local recurrence | 1 (1.4) | – | 1 (3.2) | |
| Pancreatic cancer | 1 (1.4) | – | 1 (3.2) | |
| Heart failure | 1 (1.4) | 1 (2.3) | – | |
| Herpes encephalitis | 1 (1.4) | – | 1 (3.2) | |
| Median observation period, month (range) | 52.0 (6.5–157.6) | 38.8 (6.5–157.6) | 59.8 (9.3–143.6) | 0.123 |
APC algon plasma coagulation, EP endoscopic papillectomy, PD pancreatoduodenectomy.